Bariatric surgery tied to fewer cerebrovascular events

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Intranasal Midazolam as First Line Treatment for Status Epilepticus

Publish date:: September 3, 2019

Key clinical point: When a patient in status epilepticus doesn’t already have an intravenous line in place, alternative routes of benzodiazepine administration become more attractive.

Major finding: About 57% of patients experienced cessation of their status epilepticus an average of 5 minutes after receiving intranasal midazolam.

Study details: This was a prospective, observational study of 42 patients who received intranasal midazolam as first-line treatment for their status epilepticus.

Disclosures: The presenter reported having no financial conflicts regarding her study, conducted free of commercial support.

Citation:

Kay L et al. IEC 2019, Abstract P029.

This Week's Must Reads

Cardiac Arrhythmia Heightens Mortality Risk During Epilepsy Hospitalizations,

High Infantile Spasm Risk Should Contraindicate Sodium Channel Blocker Antiepileptics,

Study Delineates Spectrum of Dravet Syndrome Phenotypes,

Bariatric Surgery Tied to Fewer Cerebrovascular Events,

Reduction in convulsive seizure frequency is associated with improved executive function in Dravet syndrome,

Must Reads in Epilepsy & Seizures

Cardiac Arrhythmia Heightens Mortality Risk During Epilepsy Hospitalizations,

High Infantile Spasm Risk Should Contraindicate Sodium Channel Blocker Antiepileptics,

Study Delineates Spectrum of Dravet Syndrome Phenotypes,

Reduction in convulsive seizure frequency is associated with improved executive function in Dravet syndrome,

Moderate coffee intake associated with few seizures in drug-refractory patients with epilepsy,

Menu Close